Dawn O. Kleindorfer, MD, FAHA, Chair; Amytis Towfighi, MD, FAHA, Vice Chair; Seemant
Chaturvedi, MD, FAHA; Kevin M. Cockroft, MD, MSc, FAHA; Jose Gutierrez, MD, MPH; …

In the absence of contemporary, population-based epidemiological studies, estimates of the
incidence and prevalence of the inherited cardiomyopathies have been derived from …

Meta‐analyses have been increasingly used to synthesize proportions (eg, disease
prevalence) from multiple studies in recent years. Arcsine‐based transformations, especially …

Purpose Genetic testing has advanced significantly since the publication of the 2011
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …

Background Pathology testing and diagnostic imaging together contribute 9% of
healthcare's carbon footprint. Whilst the carbon footprint of pathology testing has been …

Excessive trabeculation, often referred to as “noncompacted” myocardium, has been
described at all ages, from the fetus to the adult. Current evidence for myocardial …

Background: Although left ventricular noncompaction (LVNC) has been associated with an
increased risk of adverse cardiovascular events, the accurate incidence of cardiovascular …

Purpose To characterize the genetic architecture of left ventricular noncompaction (LVNC)
and investigate the extent to which it may represent a distinct pathology or a secondary …

Genetic diseases that affect the cardiovascular system are relatively common and include
cardiac channelopathies, cardiomyopathies, aortopathies, hypercholesterolemias, and …

Background Left ventricular noncompaction (LVNC) is a heterogeneous entity with uncertain
prognosis. Objectives This study sought to develop and validate a prediction model of major …